Glioma epidemiology and demographics: Difference between revisions
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Glioma is the common primary intracranial tumor. The incidence of glioma is estimated to be 4.9 cases per 100,000 individuals in the US. Males are more commonly affected with glioma than females.<ref name="pmid16932614">{{cite journal| author=Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M| title=Epidemiology and molecular pathology of glioma. | journal=Nat Clin Pract Neurol | year= 2006 | volume= 2 | issue= 9 | pages= 494-503; quiz 1 p following 516 | pmid=16932614 | doi=10.1038/ncpneuro0289 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16932614 }} </ref> | Glioma is the common primary intracranial tumor. The incidence of glioma is estimated to be 4.9 cases per 100,000 individuals in the US. Males are more commonly affected with glioma than females.<ref name="pmid16932614">{{cite journal| author=Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M| title=Epidemiology and molecular pathology of glioma. | journal=Nat Clin Pract Neurol | year= 2006 | volume= 2 | issue= 9 | pages= 494-503; quiz 1 p following 516 | pmid=16932614 | doi=10.1038/ncpneuro0289 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16932614 }} </ref> Patients of all age groups may develop glioma. It usually affects individuals of the caucasian race. African american, latin american, and asian individuals are less likely to develop glioma. | ||
==Epidemiology and demographics== | ==Epidemiology and demographics== | ||
| Line 13: | Line 13: | ||
==Age== | ==Age== | ||
Patients of all age groups may develop glioma. | *Patients of all age groups may develop glioma. | ||
*[[Pilocytic astrocytoma]] is a common disease that tends to affect children and young adults. The median age at diagnosis is 17 years. | *[[Pilocytic astrocytoma]] is a common disease that tends to affect children and young adults. The median age at diagnosis is 17 years. | ||
*[[Glioblastoma multiforme]] is a common disease that tends to affect elderly population. The median age at diagnosis is 62 years. | *[[Glioblastoma multiforme]] is a common disease that tends to affect elderly population. The median age at diagnosis is 62 years. | ||
Revision as of 17:12, 22 September 2015
|
Glioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Glioma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Glioma epidemiology and demographics |
|
Risk calculators and risk factors for Glioma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Glioma is the common primary intracranial tumor. The incidence of glioma is estimated to be 4.9 cases per 100,000 individuals in the US. Males are more commonly affected with glioma than females.[1] Patients of all age groups may develop glioma. It usually affects individuals of the caucasian race. African american, latin american, and asian individuals are less likely to develop glioma.
Epidemiology and demographics
Incidence
- Glioma is the common primary intracranial tumor.
- The incidence of glioma is estimated to be 4.9 cases per 100,000 individuals in the US.[1]
Age
- Patients of all age groups may develop glioma.
- Pilocytic astrocytoma is a common disease that tends to affect children and young adults. The median age at diagnosis is 17 years.
- Glioblastoma multiforme is a common disease that tends to affect elderly population. The median age at diagnosis is 62 years.
Gender
Males are more commonly affected with glioma than females.[1]
Race
Glioma usually affects individuals of the caucasian race. African american, latin american, and asian individuals are less likely to develop glioma.
References
- ↑ 1.0 1.1 1.2 Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M (2006). "Epidemiology and molecular pathology of glioma". Nat Clin Pract Neurol. 2 (9): 494–503, quiz 1 p following 516. doi:10.1038/ncpneuro0289. PMID 16932614.